FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2081923162> ?p ?o ?g. }

• W2081923162 endingPage "252" @default.
• W2081923162 startingPage "247" @default.
• W2081923162 abstract "Background Hormone receptor (HR) and HER2 signaling pathways are involved in the regulation of breast cancer proliferation. The impact of HR status on the clinical outcome of patients with HER2-overexpressing disease treated with the monoclonal antibody trastuzumab is unknown. Patients and Methods To evaluate this, we conducted a retrospective analysis of 805 patients with metastatic breast cancer enrolled in 3 clinical trials comparing trastuzumab in combination with chemotherapy versus chemotherapy alone or trastuzumab monotherapy as first-, second-, or third-line treatment. Patients whose tumor samples overexpressed HER2 by fluorescence in situ hybridization (FISH) were stratified based on HR status, and clinical outcomes were compared. Results Tumor samples from 596 of 805 patients were HER2overexpressing by FISH; 45% of these were HR-positive and 43% were HR-negative (HR status was unknown in 12%). Overall response rate (ORR) and time to progression (TTP) were significantly higher in patients treated with chemotherapy plus trastuzumab than in those treated with chemotherapy alone, irrespective of HR status. Median survival was longer for patients with HR-positive tumors receiving combination therapy compared with those with HR-negative tumors. In the trastuzumab monotherapy trials, ORR and TTP were similar for patients with HR-positive and HR-negative tumors. Median survival was longer for patients with HR-positive tumors compared with those with HR-negative tumors. Conclusion Hormone receptor status did not affect the clinical benefit of trastuzumab given as a single agent or combined with chemotherapy. The addition of trastuzumab to chemotherapy provides an improved clinical benefit compared with chemotherapy alone, regardless of HR status." @default.
• W2081923162 created "2016-06-24" @default.
• W2081923162 creator A5013134881 @default.
• W2081923162 creator A5027209040 @default.
• W2081923162 creator A5032364795 @default.
• W2081923162 creator A5044108002 @default.
• W2081923162 creator A5068617413 @default.
• W2081923162 date "2005-08-01" @default.
• W2081923162 modified "2023-10-18" @default.
• W2081923162 title "Hormone Receptor Status Does Not Affect the Clinical Benefit of Trastuzumab Therapy for Patients with Metastatic Breast Cancer" @default.
• W2081923162 cites W1486460534 @default.
• W2081923162 cites W1592402252 @default.
• W2081923162 cites W1605523334 @default.
• W2081923162 cites W1807228574 @default.
• W2081923162 cites W1820219315 @default.
• W2081923162 cites W1837870834 @default.
• W2081923162 cites W1881538131 @default.
• W2081923162 cites W1901376003 @default.
• W2081923162 cites W1922272927 @default.
• W2081923162 cites W1932878073 @default.
• W2081923162 cites W1955382134 @default.
• W2081923162 cites W1978797801 @default.
• W2081923162 cites W1978994512 @default.
• W2081923162 cites W1984988266 @default.
• W2081923162 cites W1996015692 @default.
• W2081923162 cites W2006720018 @default.
• W2081923162 cites W2034559462 @default.
• W2081923162 cites W2040077715 @default.
• W2081923162 cites W2054430764 @default.
• W2081923162 cites W2062713892 @default.
• W2081923162 cites W2064347883 @default.
• W2081923162 cites W2066699592 @default.
• W2081923162 cites W2074062119 @default.
• W2081923162 cites W2077363843 @default.
• W2081923162 cites W2080516316 @default.
• W2081923162 cites W2091864171 @default.
• W2081923162 cites W2095156669 @default.
• W2081923162 cites W2100191114 @default.
• W2081923162 cites W2101577390 @default.
• W2081923162 cites W2109388713 @default.
• W2081923162 cites W2115759102 @default.
• W2081923162 cites W2131475305 @default.
• W2081923162 cites W2141217952 @default.
• W2081923162 cites W2141393790 @default.
• W2081923162 cites W2145257123 @default.
• W2081923162 cites W2159459001 @default.
• W2081923162 cites W2170832900 @default.
• W2081923162 cites W2318605753 @default.
• W2081923162 cites W4293241248 @default.
• W2081923162 doi "https://doi.org/10.3816/cbc.2005.n.027" @default.
• W2081923162 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16137436" @default.
• W2081923162 hasPublicationYear "2005" @default.
• W2081923162 type Work @default.
• W2081923162 sameAs 2081923162 @default.
• W2081923162 citedByCount "46" @default.
• W2081923162 countsByYear W20819231622012 @default.
• W2081923162 countsByYear W20819231622013 @default.
• W2081923162 countsByYear W20819231622015 @default.
• W2081923162 countsByYear W20819231622016 @default.
• W2081923162 countsByYear W20819231622017 @default.
• W2081923162 countsByYear W20819231622018 @default.
• W2081923162 countsByYear W20819231622019 @default.
• W2081923162 countsByYear W20819231622022 @default.
• W2081923162 countsByYear W20819231622023 @default.
• W2081923162 crossrefType "journal-article" @default.
• W2081923162 hasAuthorship W2081923162A5013134881 @default.
• W2081923162 hasAuthorship W2081923162A5027209040 @default.
• W2081923162 hasAuthorship W2081923162A5032364795 @default.
• W2081923162 hasAuthorship W2081923162A5044108002 @default.
• W2081923162 hasAuthorship W2081923162A5068617413 @default.
• W2081923162 hasConcept C121608353 @default.
• W2081923162 hasConcept C126322002 @default.
• W2081923162 hasConcept C143998085 @default.
• W2081923162 hasConcept C23589133 @default.
• W2081923162 hasConcept C2775930923 @default.
• W2081923162 hasConcept C2776694085 @default.
• W2081923162 hasConcept C2779786085 @default.
• W2081923162 hasConcept C530470458 @default.
• W2081923162 hasConcept C535046627 @default.
• W2081923162 hasConcept C71924100 @default.
• W2081923162 hasConceptScore W2081923162C121608353 @default.
• W2081923162 hasConceptScore W2081923162C126322002 @default.
• W2081923162 hasConceptScore W2081923162C143998085 @default.
• W2081923162 hasConceptScore W2081923162C23589133 @default.
• W2081923162 hasConceptScore W2081923162C2775930923 @default.
• W2081923162 hasConceptScore W2081923162C2776694085 @default.
• W2081923162 hasConceptScore W2081923162C2779786085 @default.
• W2081923162 hasConceptScore W2081923162C530470458 @default.
• W2081923162 hasConceptScore W2081923162C535046627 @default.
• W2081923162 hasConceptScore W2081923162C71924100 @default.
• W2081923162 hasIssue "3" @default.
• W2081923162 hasLocation W20819231621 @default.
• W2081923162 hasLocation W20819231622 @default.
• W2081923162 hasOpenAccess W2081923162 @default.
• W2081923162 hasPrimaryLocation W20819231621 @default.
• W2081923162 hasRelatedWork W2030434439 @default.
• W2081923162 hasRelatedWork W2050439103 @default.
• W2081923162 hasRelatedWork W2218005127 @default.

• next